As a result, it was shown in this study that noninvasive CXCR4 detection by PET imaging using the 64Cu-labeled CXCR4 antagonist LY2510924 is feasible and may represent a suitable method for ESCC diagnosis. This evidence concerns the gene CXCR4 and esophageal squamous cell carcinoma.